ArticleFrontiers in immunology2023

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.

Chris David Lauruschkat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.